By bnm Tel Aviv bureau US Special Envoy Steve Witkoff announced the transition to the second phase of the ongoing Gaza peace ...

SELLAS Life Sciences Virtual R&D Day -- October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 ...

HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences, Inc. (RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (BMY) (NYSE:BMY) in collaboration with Johnson & Johnson today announced the decision to stop the Phase 3 Librexia ACS trial evaluating the ...

Phase 2b Trial of Halneuron ® in CINP underway; Interim Results Expected in 4Q25 Dogwood Therapeutics, Inc. (NASDAQ:DWTX) recently initiated the Phase 2b HALT-CINP (Halneuron Treatment of Chemotherapy ...

Shuttle Pharmaceuticals Holdings, Inc. provided a corporate update focusing on their Phase 2 clinical trial for Ropidoxuridine, aimed at treating glioblastoma. Nearly 50% of patient enrollment has ...

Greenwich LifeSciences, Inc. provided an update on its Phase III clinical trial, FLAMINGO-01, which is investigating the immunotherapy GLSI-100 for preventing breast cancer recurrences. The Data ...

Mutuum Finance (MUTM) is a new crypto project focused on decentralized lending and borrowing. As of its latest update, the project has entered Phase 7 of its token presale and continues to share ...